ArticleActa pharmacologica Sinica2026
PDE4 inhibitor rolipram dynamically regulates the balance between D1-MSNs and D2-MSNs in the DMS to modulate abnormal "Go" behavior associated with alcohol addiction.
Wei Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.